Liver disease experts point out that HBV-DNA is an indicator of hepatitis B virus replication, which positively indicates that there is hepatitis B virus replication. The content of HBV-DNA indicates whether HBV replication is active or not. At present, the lower limit of laboratory testing is 500/ml. This indicator is combined with five items: hepatitis B, liver function, B-ultrasound of liver, gallbladder and spleen, and blood routine. , which is the main reference index for patients with hepatitis B and hepatitis B virus carriers, is of great significance for determining the treatment plan and evaluating the curative effect, especially for anti-hepatitis B virus treatment.
The higher the HBV-DNA, the more severe the virus replication and the more contagious it is. If HBV DNA is positive in patients with hepatitis B, liver function and B-ultrasound should be further examined.
The positive detection of HBV-DNA indicates that there is virus replication in the body, which is relatively contagious. In this case, both patients with hepatitis B and patients with hepatitis B need antiviral treatment at this time. If the liver function of patients with hepatitis B is normal, it is suggested that patients should have liver puncture examination at this time. The results suggest that antiviral treatment should also be carried out when the liver is inflamed, especially for patients with family history of liver cancer, regardless of whether the liver is inflamed or not.